Holen Sie sich die Stockscreener-App
44.67
0.79%
0.35
Schlusskurs vom Vortag:
$44.32
Offen:
$43.84
24-Stunden-Volumen:
1.32M
Relative Volume:
1.43
Marktkapitalisierung:
$9.93B
Einnahmen:
$1.97B
Nettoeinkommen (Verlust:
$92.93M
KGV:
30.81
EPS:
1.45
Netto-Cashflow:
$459.60M
1W Leistung:
-1.61%
1M Leistung:
+6.13%
6M Leistung:
+6.64%
1J Leistung:
+3.06%
1-Tages-Spanne:
$43.78
$44.95
1-Wochen-Bereich:
$43.78
$46.08
52-Wochen-Spanne:
$39.03
$47.44
Qiagen Nv Stock (QGEN) Company Profile
Firmenname
Qiagen Nv
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie QGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
44.67 | 9.93B | 1.97B | 92.93M | 459.60M | 0.4066 |
|
TMO
Thermo Fisher Scientific Inc
|
524.05 | 200.45B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
228.55 | 165.08B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
134.51 | 38.36B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.27 | 35.80B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
412.26 | 33.76B | 3.84B | 866.24M | 792.60M | 10.37 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-10 | Hochstufung | Jefferies | Hold → Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-06-27 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-12-07 | Hochstufung | Goldman | Neutral → Buy |
| 2023-09-12 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-05-23 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-01-18 | Hochstufung | DZ Bank | Hold → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-10-14 | Eingeleitet | Redburn | Buy |
| 2021-07-14 | Herabstufung | Kepler | Buy → Hold |
| 2021-06-03 | Eingeleitet | Goldman | Neutral |
| 2020-10-06 | Fortgesetzt | BofA Securities | Buy |
| 2020-09-28 | Hochstufung | Kepler | Hold → Buy |
| 2020-08-24 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-08-17 | Hochstufung | Berenberg | Hold → Buy |
| 2020-08-14 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-08-14 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | Herabstufung | Berenberg | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-12-26 | Fortgesetzt | BofA/Merrill | Underperform |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-11-14 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-11-14 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2019-11-14 | Hochstufung | Kepler | Reduce → Hold |
| 2019-10-17 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | Herabstufung | Kepler | Hold → Reduce |
| 2019-10-08 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2019-10-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2019-10-08 | Herabstufung | JP Morgan | Neutral → Underweight |
Alle ansehen
Qiagen Nv Aktie (QGEN) Neueste Nachrichten
August 2025 Options Now Available For Qiagen (QGEN) - Nasdaq
Qiagen Announces AFM Notification on BlackRock Shareholding - TipRanks
Qiagen Highlights BlackRock’s Indirect Stake in Voting Rights Disclosure - TipRanks
State Street Corp Boosts Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
QIAGEN Stock Gains Following the Latest Launch of IPA Interpret - MSN
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
QIAGEN Launches Ingenuity Pathway Analysis Interpret - Marketscreener.com
QIAGEN Launches AI-Extension of Ingenuity Pathway Analysis for Automatic Interpretation of Biological Data - Business Wire
Public Employees Retirement System of Ohio Buys Shares of 214,400 Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Shares Bought by Barclays PLC - MarketBeat
QIAGEN Unveils AI-Powered IPA Interpret Platform to Transform Biological Data Analysis - StockTitan
Qiagen (NYSE:QGEN) Stock Holdings Lifted by XTX Topco Ltd - MarketBeat
Qiagen (NYSE:QGEN) Given "Buy" Rating at Jefferies Financial Group - MarketBeat
Qiagen (NYSE:QGEN) Seems To Use Debt Rather Sparingly - Simply Wall St
Point72 Asset Management L.P. Trims Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
Janus Henderson Group PLC Reduces Holdings in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Stock Might Rise Following 1000 EZ2 Connect Placements - MSN
Qiagen shares get Buy rating, $54 target from Jefferies By Investing.com - Investing.com Canada
Qiagen shares get Buy rating, $54 target from Jefferies - Investing.com
Jefferies Starts Qiagen NV (QGEN) at Buy - StreetInsider.com
QIAGEN Wins FDA Clearance of QIAstat-Dx Meningitis/Encephalitis Panel - MPO-mag
Quantinno Capital Management LP Has $3.56 Million Stock Position in Qiagen (NYSE:QGEN) - MarketBeat
25,658 Shares in Qiagen (NYSE:QGEN) Acquired by Verition Fund Management LLC - MarketBeat
Qiagen (QGEN) Down 1.6% Since Last Earnings Report: Can It Rebound? - MSN
Fmr LLC Raises Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Should You Continue to Retain QIAGEN Stock in Your Portfolio Now? - MSN
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 321,182 Shares of Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Reaches Milestone With Over 1,000 Placements of EZ2 Connect Sample Preparation Instrument, Driving Laboratory Automation - Silicon Canals
Proteinase K Market to hit USD 2.5 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.
Edgestream Partners L.P. Reduces Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Parkman Healthcare Partners LLC Decreases Stock Holdings in Qiagen (NYSE:QGEN) - MarketBeat
219,245 Shares in Qiagen (NYSE:QGEN) Purchased by Holocene Advisors LP - MarketBeat
Exosome Research Products Industry Research Report 2023-2030, Featuring AMS, Bio-Techne, Lonza, Miltenyi Biotech, Nanosomix, Norgen Biotek, NX Pharmagen, Qiagen, SBI, Thermo Fisher Scientific - Yahoo Finance
Point72 Hong Kong Ltd Boosts Holdings in Qiagen (NYSE:QGEN) - MarketBeat
Qiagen (NYSE:QGEN) Stock Holdings Increased by Public Sector Pension Investment Board - MarketBeat
Qiagen (NYSE:QGEN) Shares Acquired by Zurcher Kantonalbank Zurich Cantonalbank - MarketBeat
FY2024 Earnings Forecast for Qiagen Issued By Zacks Research - MarketBeat
Here's Why Qiagen (QGEN) is a Strong Value Stock - Yahoo Finance
Martingale Asset Management L P Decreases Position in Qiagen (NYSE:QGEN) - MarketBeat
QGEN Stock to Gain From Expanding QIAstat-Dx With New Barcelona Site - Yahoo Finance
QIAGEN announces new site in Barcelona for QIAstat-Dx operations - Medical Device Network
QIAGEN introduces new custom tools for microbial analysis - Yahoo Finance
Quantbot Technologies LP Has $3.31 Million Stake in Qiagen (NYSE:QGEN) - MarketBeat
QIAGEN Expands Diagnostic Operations with New 8,000sqm Barcelona Facility for QIAstat-Dx | QGEN Stock News - StockTitan
QIAGEN launches novel tools for customizing digital PCR assays and NGS panels for microbial analysis - GlobeNewswire
QIAGEN Unveils Diagnostic Assay in the EU to Detect Genetic Variation Causing Adverse Reactions in AIDS Patients - br.ADVFN.com
Qiagen (NYSE:QGEN) Shares Sold by Citigroup Inc. - MarketBeat
QIAGEN Launches Groundbreaking Custom Microbial Analysis Tools for Digital PCR & NGS - StockTitan
QIAGEN Gains FDA Clearance for Latest Respiratory Mini-Panel Test - MPO-mag
Here's Why Qiagen (QGEN) is a Strong Momentum Stock - Yahoo Finance
Finanzdaten der Qiagen Nv-Aktie (QGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):